Daytime Napping and Mortality Association in Older Adults

Why It Matters

Identifying napping behavior as a low‑cost biomarker could help clinicians flag older patients at elevated health risk, prompting earlier investigation of underlying conditions such as cardiovascular disease or inflammation.

Key Takeaways

• Longer naps add mortality risk equivalent to 1.1 years aging
• Each extra daily nap equals ~0.6 years added age risk
• Morning naps raise risk similar to being 2.5 years older
• Wearable‑tracked nap patterns may serve as early health indicators

Pulse Analysis

Daytime napping is a common habit among seniors, with estimates ranging from one‑fifth to three‑quarters of older adults taking at least one nap per day. While brief naps can boost alertness, a growing body of epidemiological research has linked prolonged or frequent naps to adverse outcomes, including cardiovascular events and neurodegeneration. The new JAMA Network Open analysis adds weight to these concerns by leveraging actigraphy—a wearable sensor that records movement—to capture nap duration and frequency with objective precision, overcoming the self‑report bias that has limited earlier studies.

The study followed participants from the Rush Memory and Aging Project for up to eight years, recording up to 14 days of continuous actigraphy data per individual. Results showed a clear dose‑response relationship: an extra hour of nap time translated to a mortality risk comparable to being 1.1 years older, and each additional daily nap added risk akin to 0.6 years of aging. Notably, naps taken in the early morning (9 am‑1 pm) were associated with the steepest risk increase—about 2.5 years of additional biological age—whereas the link vanished among cognitively intact participants, suggesting that underlying brain health may mediate the association.

For clinicians and health‑tech innovators, these findings highlight nap patterns as a potentially inexpensive, continuously monitorable biomarker. Wearable devices already track sleep and activity; integrating nap‑specific algorithms could flag patients who warrant deeper cardiovascular or inflammatory assessments. However, the authors stress that correlation does not equal causation; excessive napping likely reflects underlying disease, sleep disorders, or circadian disruption. Future research should explore whether interventions that normalize nap behavior—or address its root causes—can translate into measurable longevity benefits.